2m 2m 2m 2m 2m 2m 2m
X4 PHARMA (XFOR)
NASDAQ
$4.06+$0.09 (+2.34%)
Price as of Jun 03, 2026 7:55 PM EDT- $406.5MMarket Cap
- 2.02%1-Year Change
- BiotechnologyIndustry
X4 PHARMA (XFOR)
$4.06+$0.09 (+2.34%)
XFOR | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $3.97 | ||
Change | -$0.07 (-1.73%) | ||
Open | $4.04 | ||
High | $4.09 | ||
Low | $3.96 | ||
Previous Close | $4.04 | ||
Volume | 400,251 | ||
30-Day Average Volume | 376,580 | ||
1-Week Change | -1.49% | ||
1-Month Change | -5.25% | ||
1-Year Change | -1.73% | ||
3-Year Change | -93.98% | ||
5-Year Change | -98.57% | ||
Fundamentals | |||
Shares Outstanding | 94.3M | ||
Total Assets | $270.3M | ||
Market Cap | $406.5M | ||
Enterprise Value | $264.6M | ||
Period: QTR TTM FY | |||
Revenue | $239,000.00 | ||
Net Income | -$20.2M | ||
Free Cash Flow | -$19.6M | ||
EBIT | -$18.1M | ||
EBITDA | -$17.9M | ||
Net Working Capital | $218.2M | ||
EPS | -$0.16 | ||
Enterprise Value/EBITDA | -15 | ||
Enterprise Value/Revenue | 1,107 | ||
P/B | 2 | ||
P/E | -27 | ||
PEG | -1 | ||
Price/Free Cash Flow | -21 | ||
Price/Operating Cash Flow | -21 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 30 | ||
Last Split Date | 04/28/2025 | ||
Earnings & Revenue